The Randomized Clinical Trial: Beware of Limitations

Journal of Glaucoma

Volumn 13, Issue 2, 2004, Pages 87-89

  Singh, Kuldev ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; EDITORIAL; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; REPRODUCIBILITY;

BIAS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; GLAUCOMA; HUMANS; MULTICENTER STUDIES; OPHTHALMOLOGY; RANDOMIZED CONTROLLED TRIALS;

EID: 1642378982     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200404000-00001     Document Type: Editorial

References (8)

1. Meinert CL. The gold standard for evaluation of therapy. Ophthalmology. 1996;103:869-870.
2. AGIS Investigators. The Relationship Between Control of Intraocular Pressure and Visual Field Deterioration. Am J Ophthalmol. 2000;130: 429-440.
3. Steinmann WC in Wilson RP. Yearbook of Ophthalmology. St. Louis, MO: CV Mosby, 2001.
4. McCormick J. The Multifactorial Aetiology of Coronary Heart Disease: A Dangerous Delusion. Perspect Biol Med. 1988;32:103-108.
5. Stehbens WE. Variance and Dissent: The Quality of Epidemiological Data in Coronary Heart Disease and Atherosclerosis. J Clin Epidemiol. 1993;46:1337-1346.
6. Werko L. Risk Factors and Coronary Heart Disease - Facts or Fancy? 1976. American Heart Journal; 91(1): 87-98.
7. Leske MC, Heijl A, Hussein M. et al for the Early Manifest Glaucoma Trial Group. Factors for Glaucoma Progression and the Effect of Treatment: The Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121: 48-56.
8. Lichter PR, Musch DC, Gillespie BW, et al. Interim Clinical Outcomes in the Collaborative Initial Glaucoma Treatment Study Comparing Initial Treatment Randomized to Medications or Surgery. Ophthalmology. 2001;108:1943-1953.